These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 16889879)
1. Bayesian population analysis of a harmonized physiologically based pharmacokinetic model of trichloroethylene and its metabolites. Hack CE; Chiu WA; Jay Zhao Q; Clewell HJ Regul Toxicol Pharmacol; 2006 Oct; 46(1):63-83. PubMed ID: 16889879 [TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Abbas R; Fisher JW Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303 [TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice. Greenberg MS; Burton GA; Fisher JW Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286 [TBL] [Abstract][Full Text] [Related]
4. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Fisher JW; Mahle D; Abbas R Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003 [TBL] [Abstract][Full Text] [Related]
5. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach. Chiu WA; Okino MS; Evans MV Toxicol Appl Pharmacol; 2009 Nov; 241(1):36-60. PubMed ID: 19660485 [TBL] [Abstract][Full Text] [Related]
6. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly. Evans MV; Chiu WA; Okino MS; Caldwell JC Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323 [TBL] [Abstract][Full Text] [Related]
7. The extent of dichloroacetate formation from trichloroethylene, chloral hydrate, trichloroacetate, and trichloroethanol in B6C3F1 mice. Merdink JL; Gonzalez-Leon A; Bull RJ; Schultz IR Toxicol Sci; 1998 Sep; 45(1):33-41. PubMed ID: 9848108 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of chloral hydrate and its metabolites in male human volunteers. Merdink JL; Robison LM; Stevens DK; Hu M; Parker JC; Bull RJ Toxicology; 2008 Mar; 245(1-2):130-40. PubMed ID: 18243465 [TBL] [Abstract][Full Text] [Related]
9. Trichloroacetic acid: updated estimates of its bioavailability and its contribution to trichloroethylene-induced mouse hepatomegaly. Chiu WA Toxicology; 2011 Jul; 285(3):114-25. PubMed ID: 21549800 [TBL] [Abstract][Full Text] [Related]
10. A review of analytical methods for the determination of trichloroethylene and its major metabolites chloral hydrate, trichloroacetic acid and dichloroacetic acid. Delinsky AD; Bruckner JV; Bartlett MG Biomed Chromatogr; 2005 Oct; 19(8):617-39. PubMed ID: 15828053 [TBL] [Abstract][Full Text] [Related]
11. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice. Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684 [TBL] [Abstract][Full Text] [Related]
12. The absorption of trichloroethylene and its metabolites from the urinary bladder of anesthetized dogs. Hobara T; Kobayashi H; Kawamoto T; Iwamoto S; Sakai T Toxicology; 1988 Feb; 48(2):141-53. PubMed ID: 3341043 [TBL] [Abstract][Full Text] [Related]
13. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Clewell HJ; Gentry PR; Covington TR; Gearhart JM Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):283-305. PubMed ID: 10807559 [TBL] [Abstract][Full Text] [Related]
14. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Templin MV; Parker JC; Bull RJ Toxicol Appl Pharmacol; 1993 Nov; 123(1):1-8. PubMed ID: 8236248 [TBL] [Abstract][Full Text] [Related]
15. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models. Hack CE Toxicology; 2006 Apr; 221(2-3):241-8. PubMed ID: 16466842 [TBL] [Abstract][Full Text] [Related]
16. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone. Mörk AK; Jonsson F; Johanson G Toxicol Appl Pharmacol; 2009 Nov; 240(3):423-32. PubMed ID: 19660484 [TBL] [Abstract][Full Text] [Related]
17. Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat, and human liver microsomes. Elfarra AA; Krause RJ; Last AR; Lash LH; Parker JC Drug Metab Dispos; 1998 Aug; 26(8):779-85. PubMed ID: 9698293 [TBL] [Abstract][Full Text] [Related]
18. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594 [TBL] [Abstract][Full Text] [Related]
19. Bayesian analysis of a physiologically based pharmacokinetic model for perchloroethylene in humans. Qiu J; Chien YC; Bruckner JV; Fisher JW J Toxicol Environ Health A; 2010; 73(1):74-91. PubMed ID: 19953421 [TBL] [Abstract][Full Text] [Related]
20. In vivo effects of naproxen, salicylic acid, and valproic acid on the pharmacokinetics of trichloroethylene and metabolites in rats. Rouhou MC; Charest-Tardif G; Haddad S J Toxicol Environ Health A; 2015; 78(11):671-84. PubMed ID: 26039745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]